Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients

Overview of attention for article published in Frontiers in immunology, June 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 34,224 followers.

RT @FrontImmunol: New Research: Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA CO…

13 Jun 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA CO…

13 Jun 2023

Reply Repost Favourite

New Research: Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients: Due to rare but major adverse reactions to the AstraZeneca adenoviral… #immunology https

13 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.